Lantern Pharma LTRN - 옵션 체인 | ADVFN

다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

Lantern Pharma Inc (LTRN)

3.92

0.03

( 0.77% )

업데이트: 02:01:47

LTRN 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
1.00	1.60	4.80	0.00	3.20	0.00	0.00 %	0	0	-
2.00	1.40	3.60	0.00	2.50	0.00	0.00 %	0	0	-
3.00	0.45	2.60	0.00	1.525	0.00	0.00 %	0	0	-
4.00	0.70	2.10	0.70	1.40	0.00	0.00 %	0	43	-
5.00	0.20	0.80	0.20	0.50	0.00	0.00 %	0	16	-
6.00	0.00	0.25	0.00	0.00	0.00	0.00 %	0	0	-
7.00	0.00	1.00	0.00	0.00	0.00	0.00 %	0	0	-
8.00	0.00	2.95	0.00	0.00	0.00	0.00 %	0	0	-
9.00	0.00	2.95	0.00	0.00	0.00	0.00 %	0	0	-
10.00	0.00	2.00	0.00	0.00	0.00	0.00 %	0	0	-
11.00	0.00	2.95	0.00	0.00	0.00	0.00 %	0	0	-

개인 투자자를 위한 전문가급 도구.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
1.00	0.00	2.00	0.00	0.00	0.00	0.00 %	0	0	-
2.00	0.00	0.05	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
4.00	0.10	1.85	0.00	0.975	0.00	0.00 %	0	0	-
5.00	0.90	2.90	0.00	1.90	0.00	0.00 %	0	0	-
6.00	0.75	4.10	0.00	2.425	0.00	0.00 %	0	0	-
7.00	2.35	4.00	1.25	3.175	0.00	0.00 %	0	0	-
8.00	3.90	4.90	2.85	4.40	0.00	0.00 %	0	0	-
9.00	4.80	6.00	0.00	5.40	0.00	0.00 %	0	0	-
10.00	5.90	6.70	0.00	6.30	0.00	0.00 %	0	0	-
11.00	6.30	8.90	0.00	7.60	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
AGMHAGM Group Holdings Inc	US$ 0.2038 (99.22%)	566.93M
PSTVPlus Therapeutics Inc	US$ 0.6748 (92.80%)	147M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 15.3399 (39.96%)	12.02M
SCNXScienture Holdings Inc	US$ 2.86 (30.00%)	44.69M
ALXOALX Oncology Holdings Inc	US$ 1.35 (29.81%)	7.74M
BLNEEastside Distilling Inc	US$ 0.7117 (-90.38%)	5.33k
ACONAclarion Inc	US$ 1.45 (-79.29%)	32.49M
ELABPMGC Holdings Inc	US$ 0.671087 (-45.44%)	874.76k
SNBRSleep Number Corporation	US$ 7.8501 (-39.10%)	2.23M
CCLDCareCloud Inc	US$ 2.21 (-29.17%)	516.19k
AGMHAGM Group Holdings Inc	US$ 0.2038 (99.22%)	562.95M
PSTVPlus Therapeutics Inc	US$ 0.6748 (92.80%)	144.96M
NVDANVIDIA Corporation	US$ 111.95 (-4.56%)	123.79M
GVVisionary Holdings Inc	US$ 4.38 (18.54%)	113.16M
ADTXAditxt Inc	US$ 0.059 (-0.67%)	83M

Monksdream

Monksdream 6 월 전

anabu9

anabu9 7 월 전

Finally an UP day. 'hope institutions will see this nugget soon

FALCON1

FALCON1 7 월 전

https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri
https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation

dinogreeves

dinogreeves 10 월 전

🕳️ 1 🪦 1 ⚰️ 1

Monksdream

Monksdream 10 월 전

Monksdream

Monksdream 11 월 전

Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc

dinogreeves

dinogreeves 11 월 전

Monk, take a look at ANV*S. Data is due sometime in April, Parkinsons and Alzheimers. They just did a private placement on Friday and another one today to an institutional investor. "Subject to Certain Conditions". Looks like April is go time.

dinogreeves

dinogreeves 12 월 전

I think we can revisit the high again hopefully this week. Been here since 7.20

spartex

spartex 12 월 전

10-K filing, Earnings Webcast, Presentation in link below from LTRN company website

https://ir.lanternpharma.com/news-events/press-releases/detail/150/lantern-pharma-reports-fourth-quarter-fiscal-year-2023

Monksdream

Monksdream 12 월 전

dinogreeves

dinogreeves 12 월 전

Another very good day today.

Monksdream

Monksdream 12 월 전

LTRN 10Q due 3/18

dinogreeves

dinogreeves 12 월 전

Very good move on Friday.

🪦 1 ☠️ 1 ⚰️ 1 ⚱️ 1

dinogreeves

dinogreeves 12 월 전

This company will see 3 digit dollars, how soon? All depends on just one science behind their Artificial Intelligence to decode one cancer indication the rest will be history.

dinogreeves

dinogreeves 12 월 전

This is going to have one heck of a run.

Tremors!

Tremors! 12 월 전

Will they break 10.00!??

Roily23

Roily23 1 년 전

Roily23

Roily23 1 년 전

AI is the next .com and AI's application in medicine and pharma will be a game changer.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. It develops LP-100 for treatment in combination with the class of anticancer agent known as PARP inhibitors. The company also develops LP-300 as a combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; and LP-284, a novel small molecule and DNA damaging agent for the treatment of mantle cell lymphoma and double hit lymphoma. In addition, it offers LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관